Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1979-11-21
|
pubmed:abstractText |
Eight male schizophrenics were treated in an open study with d.l. propranolol. The dose was increased by 160 mg/day until a maximum of 2,400 mg/day was achieved on day 15, and this remained constant until day 21. Seven patients showed significant clinical evidence of psychiatric improvement, while the incidence of toxic side-effects was low. There was wide inter-patient variation in plasma levels of propranolol. Despite a significant increase of plasma propranolol between day 15 and day 21 of the study, there was no significant change in serum prolactin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-1250
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
470-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:476356-Adult,
pubmed-meshheading:476356-Drug Administration Schedule,
pubmed-meshheading:476356-Follow-Up Studies,
pubmed-meshheading:476356-Humans,
pubmed-meshheading:476356-Male,
pubmed-meshheading:476356-Middle Aged,
pubmed-meshheading:476356-Prolactin,
pubmed-meshheading:476356-Propranolol,
pubmed-meshheading:476356-Psychiatric Status Rating Scales,
pubmed-meshheading:476356-Schizophrenia
|
pubmed:year |
1979
|
pubmed:articleTitle |
High-dose propranolol in schizophrenia.
|
pubmed:publicationType |
Journal Article
|